Barbieri CE - Search Results

1

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE. Shoag J, et al. Among authors: barbieri ce. Eur Urol. 2016 Jul;70(1):2-5. doi: 10.1016/j.eururo.2016.01.009. Epub 2016 May 7. Eur Urol. 2016. PMID: 27166670 Free PMC article. Clinical Trial.

2

Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.

Barbieri CE, Schwartz MJ, Boorjian SA, Lee MM, Scherr DS. Barbieri CE, et al. Urology. 2010 Dec;76(6):1496-500. doi: 10.1016/j.urology.2010.01.035. Epub 2010 Apr 9. Urology. 2010. PMID: 20381836

3

Tissue-based molecular markers for bladder cancer.

Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF. Barbieri CE, et al. Minerva Urol Nefrol. 2010 Sep;62(3):241-58. Minerva Urol Nefrol. 2010. PMID: 20940694 Review.

4

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.

Barbieri CE, Cha EK, Chromecki TF, Dunning A, Lotan Y, Svatek RS, Scherr DS, Karakiewicz PI, Sun M, Mazumdar M, Shariat SF. Barbieri CE, et al. BJU Int. 2012 Mar;109(5):685-90. doi: 10.1111/j.1464-410X.2011.010419.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851550

5

Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.

Shariat SF, Chromecki TF, Hoefer J, Barbieri CE, Scherr DS, Karakiewicz PI, Roehrborn CG, Montorsi F, Culig Z, Cavarretta IT. Shariat SF, et al. Among authors: barbieri ce. J Urol. 2011 Nov;186(5):2107-14. doi: 10.1016/j.juro.2011.06.048. Epub 2011 Sep 23. J Urol. 2011. PMID: 21944124

6

The mutational landscape of prostate cancer.

Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Grönberg H, Luo J, Visakorpi T, Rubin MA. Barbieri CE, et al. Eur Urol. 2013 Oct;64(4):567-76. doi: 10.1016/j.eururo.2013.05.029. Epub 2013 May 18. Eur Urol. 2013. PMID: 23759327 Free PMC article. Review.

7

Molecular characterization of prostate cancer following androgen deprivation: the devil in the details.

Barbieri CE, Rubin MA. Barbieri CE, et al. Eur Urol. 2014 Jul;66(1):40-1. doi: 10.1016/j.eururo.2013.08.056. Epub 2013 Aug 30. Eur Urol. 2014. PMID: 24011425 No abstract available.

8

Evolution of novel biomarkers for detection of prostate cancer.

Barbieri CE. Barbieri CE. J Urol. 2013 Dec;190(6):1970-1. doi: 10.1016/j.juro.2013.09.018. Epub 2013 Sep 14. J Urol. 2013. PMID: 24045221 No abstract available.

9

The lethal clone in prostate cancer: redefining the index.

Barbieri CE, Demichelis F, Rubin MA. Barbieri CE, et al. Eur Urol. 2014 Sep;66(3):395-7. doi: 10.1016/j.eururo.2013.12.052. Epub 2014 Jan 2. Eur Urol. 2014. PMID: 24411284 No abstract available.

10

Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.

Otto B, Barbieri C, Lee R, Te AE, Kaplan SA, Robinson B, Chughtai B. Otto B, et al. Adv Urol. 2014;2014:627290. doi: 10.1155/2014/627290. Epub 2014 Apr 29. Adv Urol. 2014. PMID: 24876835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page